Reply: Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany

被引：0
|
作者：
Walter, Evelyn [1 ]
Odin, Per [1 ]
机构：
[1] Hlth Econ, Inst Pharmaecon Res, Vienna, Austria
来源：
JOURNAL OF MEDICAL ECONOMICS | 2015年 / 18卷 / 11期
关键词：
DEEP-BRAIN-STIMULATION; MOTOR FLUCTUATIONS; MEDICAL THERAPY; INFUSION; TRIAL;
D O I：
10.3111/13696998.2015.1074079
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：860 / 862
页数：3
相关论文
共 50 条
  • [21] Cost-effectiveness of treatment with entacapone for patients with Parkinson's disease in the United States
    Palmer, C
    Nuijten, M
    Schmier, J
    Subedi, P
    Snyder, E
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 496 - 496
  • [22] Deep brain stimulation in the treatment of Parkinson's disease - A cost-effectiveness analysis
    Tomaszewski, KJ
    Holloway, RG
    NEUROLOGY, 2001, 57 (04) : 663 - 671
  • [23] Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson’s Disease in Japan
    Takuro Shimbo
    Kenji Hira
    Manabu Takemura
    Tsuguya Fukui
    PharmacoEconomics, 2001, 19 : 875 - 886
  • [24] Treatment of Alzheimer's disease with cholinesterase inhibitors in Germany: A cost-effectiveness study
    Faltraco, F
    Happich, M
    Reisig, V
    Teipel, SJ
    Moeller, HJ
    Hampel, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S336 - S336
  • [25] Continuous subcutaneous apomorphine infusion for the management of Parkinson's disease at the end-of-life
    Bereau, M.
    Giffard, M.
    Clairet, A. L.
    Verin, M.
    Auffret, M.
    MOVEMENT DISORDERS, 2022, 37 : S441 - S442
  • [26] Continuous subcutaneous apomorphine infusion for the management of Parkinson's disease at the end-of-life
    Bereau, M.
    Giffard, M.
    Clairet, A. L.
    Tatu, L.
    Verin, M.
    Auffret, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 66 - 67
  • [27] Ambulatory treatment with continuous subcutaneous apomorphine infusion in advanced Parkinson's disease. Experience with 34 cases
    Sesar, A.
    Ares, B.
    Rivas, M. T.
    Castro, A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S313 - S314
  • [28] Intermittent subcutaneous apomorphine in advanced Parkinson's disease
    Storch, A
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 17 - 22
  • [29] The role of subcutaneous infusion of apomorphine in Parkinson's disease
    Wenzel, Karoline
    Homann, Carl Nikolaus
    Fabbrini, Giovanni
    Colosimo, Carlo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (07) : 833 - 843
  • [30] Intermittent subcutaneous apomorphine therapy in Parkinson's disease
    Factor, SA
    NEUROLOGY, 2004, 62 (06) : S12 - S17
12345